Thursday, January 12, 2017

UPDATE 1-Eli Lilly defeats Teva appeal over Alimta cancer drug

Jan 12 (Reuters) - A U.S. appeals court on Thursday said Eli

Lilly and Co may block Teva Pharmaceutical Industries

Ltd from selling a generic equivalent of its

top-selling lung cancer drug Alimta, in...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)